Aston Martin F1 car
credit: Aston Martin Aramco/Eight Sleep
The sleep tech company will support driver and team recovery; Eight Sleep branding will also be seen on Aston Martin Aramco Formula One cars

The Aston Martin Aramco Formula One Team has entered a new partnership with Eight Sleep, bringing the sleep technology brand into its performance ecosystem ahead of the 2026 season.

The collaboration will center on recovery optimization across the team’s drivers and personnel, with Eight Sleep providing its Pod sleep systems, temperature-regulated beds equipped with biometric tracking and adaptive cooling technology designed to support improved recovery.

As the Formula One calendar grows more demanding with long-haul travel, rapid time zone shifts and condensed race weekends, the partnership goal is to improve athlete sleep patterns.

“In Formula One, performance is the result of marginal gains accumulated over an entire season,” said Jefferson Slack, the managing director of commercial and marketing for Aston Martin F1. “Sleep is a critical performance input, and Eight Sleep’s AI-powered sleep technology allows us to optimize recovery in a way that static solutions cannot.”

Eight Sleep’s technology continuously adjusts bed temperature throughout the night and tracks physiological signals to tailor sleep conditions in real time. The system is built on a large proprietary dataset and is designed to help users adapt to changing training loads, travel schedules and recovery needs.

The partnership will also extend to branding integration across the race environment. Eight Sleep’s logo will appear on the nose of the team’s car, as well as on driver balaclavas, cooling vests and garage cooling equipment during race weekends.

Eight Sleep logo on an Astin Martin F1 car
credit: Aston Martin Aramco/Eight Sleep

Eight Sleep’s partnership with Aston Martin Aramco Formula One Team comes as the company expands beyond consumer sleep products into performance and health technology.

Last fall, Eight Sleep raised $100 million in funding to develop an AI-powered “sleep agent” and pursue FDA approval for future medical applications, signaling ambitions that extend into preventive health and clinical monitoring. The capital is expected to support product innovation, global expansion and deeper integration of biometric data and AI into its sleep systems.

The company has also been building visibility through partnerships and athlete adoption, including with NBA star Jimmy Butler and F1 driver Charles Leclerc.

Tags: